10-K: DocGo Inc. Reports Fiscal Year 2024 Results, Navigates Shifting Revenue Streams

DocGo Inc.'s 2024 10-K filing reveals a year of strategic adjustments, including a net income of $13.4 million amidst declining migrant-related service revenues and growth in transportation services.

Summary

• DocGo Inc.'s 10-K filing reports a net income of $13.4 million for the fiscal year ended December 31, 2024.
• The company experienced a 1.2% decrease in total revenues, amounting to $616.6 million, compared to $624.3 million in 2023.
• Mobile Health Services revenue decreased by 4.4% to $423.1 million due to the wind-down of migrant-related services.
• Transportation Services revenue increased by 6.6% to $193.5 million, driven by a 13.7% increase in trip volumes.
• The company's cost of revenues decreased by 6.0%, resulting in a cost of revenues percentage of 65.4% compared to 68.7% in the previous year.
• Operating expenses increased by 2.6% to $184.9 million, representing 30.0% of total revenues.
• The company's government contract work accounted for 72% of revenues in 2024, 73% in 2023 and 64% in 2022.
• DocGo has $30 million outstanding under its line of credit as of December 31, 2024.
• The company's share repurchase program authorized up to $26 million in share repurchases, with $22 million remaining available as of December 31, 2024.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While the company achieved net income, there are concerns about declining revenues in Mobile Health Services and reliance on government contracts. The company is taking steps to improve its operations and expand its business, but there are also risks and uncertainties that could affect its future performance.

Positives

• Transportation Services revenue increased by 6.6% due to higher trip volumes.
• Cost of revenues decreased by 6.0%, improving the cost of revenues percentage.
• The company has an active share repurchase program.
• The company hired top leaders to bolster their team, including Yong Kim from CVS, Jen McLean from City Harvest, and Eiwe Lingefors from Capsule Pharmacy.
• The company launched DocGo's Medical Advisory Board, which includes top industry specialists from Harvard Medical School, Mount Sinai Hospital, UT Health, and VillageMD.
• Healthcare visionary Stephen K. Klasko, MD, MBA joined as the non-executive Chair of DocGo's Board of Directors.

Negatives

• Total revenues decreased by 1.2% compared to the previous year.
• Mobile Health Services revenue decreased by 4.4% due to the wind-down of migrant-related services.
• Operating expenses increased by 2.6%.

Risks

• The company's future performance is dependent on penetrating new and existing markets.
• The company faces a high level of competition in its industry.
• The company relies on government contracts, which are subject to risks and uncertainties.
• Negative media coverage could damage the company's reputation.
• The company's labor costs are significant and any inability to control those costs could adversely affect its business.
• The company's reliance on data center providers, Internet infrastructure, bandwidth providers, third-party computer hardware and software, other third parties and DocGo's own systems for providing services to DocGo's clients and consumers, and any failure or interruption in the services provided by these third parties or DocGo's own systems could expose DocGo to disputes, litigation and negatively impact DocGo's relationships with clients, adversely affecting DocGo's brand and DocGo's business.
• Security breaches, loss of data and other disruptions or cybersecurity incidents could compromise sensitive business, customer or patient information or prevent DocGo from accessing critical information and expose it to liability, which could adversely affect DocGo's business.
• The use of artificial intelligence (AI) in DocGo's operations poses inherent risks and could adversely affect DocGo's business.
• DocGo's indebtedness could require that it dedicate a portion of its cash flows to debt service obligations and reduce the funds that would otherwise be available for other general corporate purposes and other business opportunities, which could adversely affect DocGo's operating performance, growth, profitability and financial condition, which in turn could make it more difficult for it to generate cash flow sufficient to satisfy all of its obligations under its indebtedness.
• Nasdaq may delist DocGo's securities from trading on its exchange, which could limit investors' ability to make transactions in its securities and subject DocGo to additional trading restrictions.

Future Outlook

The company expects revenues from migrant-related projects to be significantly lower in 2025. Future growth will be driven by other initiatives.

Industry Context

The company operates in the competitive medical transportation and mobile health services industries, facing competition from both small local providers and large national organizations. The mobile health/telehealth market is in an early stage of development and is expected to become increasingly competitive.

Comparison to Industry Standards

• DocGo competes with companies such as DispatchHealth, Modivcare, Addus HomeCare, Option Care Health, Teladoc, Amwell, Signify Health (acquired by CVS), MedArrive, Biofourmis and One Medical (acquired by Amazon).
• The company's Net Promoter Score (NPS) for Mobile Health Services was 87, which is considered excellent.

Legal Proceedings

• The company is subject to legal proceedings, claims and litigation arising in the ordinary course of its business.
• The company is involved in a securities class action lawsuit and two purported shareholder derivative actions.
• The company is involved in a cybersecurity action.

Related Party Transactions

• The company made payments to Ely D. Tendler Strategic & Legal Services PLLC for legal services.
• The company made subcontractor payments to PrideStaff.
• The company made payments to Anthony Capone under a transition services agreement.
• The company granted RSUs to Stan Vashovsky under a consulting agreement.
• The company made payments to Steven Katz under a consulting agreement.

Stakeholder Impact

• The company's performance affects shareholders, employees, customers, suppliers, and creditors.
• The company's ability to provide quality services impacts patients and healthcare providers.
• The company's compliance with laws and regulations affects the government and the public.

Next Steps

• The company intends to develop and introduce innovative new software services, integrations with third-party products and services, mobile applications and other new offerings.
• The company plans to facilitate PCP services for health plan patients, and migrate to a value-based care model with insurance partners that includes graduated risk-sharing arrangements to reward us for improving patient outcomes while reducing the overall cost of care.

Key Dates